Jan van den Brulle serves as VP External Research & Development at T‑CURX and brings more than 20 years of experience in research and development across multiple biotechnology companies. Prior to joining T‑CURX, he held senior leadership roles at MorphoSys AG and Sloning Biotechnology, where he led large research teams, managed global pharma collaborations, and advanced multiple therapeutic antibody programs to lead candidate stage. Jan has a strong background in synthetic biology and is an inventor on numerous granted patents in the field.